CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Grant or award See Remarks acquired 63,412 shares (grant or award)
- 4 Planned sale Chief Operating Officer sold 90,806 shares at an average $16.63 ($1,509,925)
- 4 Planned sale President and CEO sold 100,000 shares at an average $16.56 ($1,656,085)
- 4 Grant or award Chief Medical Officer acquired 1,337 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,421 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,463 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Operating Officer sold 4,107 shares at an average $16.01 ($65,755)
- 4 Planned sale Chief Operating Officer sold 2,400 shares at an average $16.05 ($38,529)
- 4 Planned sale Chief Operating Officer sold 1,903 shares at an average $16.03 ($30,512)
- 4 Planned sale Chief Operating Officer sold 40,365 shares at an average $16.70 ($674,246)
- 4 Planned sale Chief Operating Officer sold 46,784 shares at an average $16.86 ($788,636)
- 4 Planned sale Chief Executive Officer sold 24,190 shares at an average $17.01 ($411,512)
- 4 Planned sale Chief Executive Officer sold 75,810 shares at an average $17.12 ($1,297,542)
- 4 Planned sale Chief Executive Officer sold 20,700 shares at an average $16.08 ($332,867)
- 4 Planned sale Chief Operating Officer sold 18,340 shares at an average $16.11 ($295,405)
- 4 Derivatives Options or other derivatives
Page 6 of 11 · 203 filings